Author/Authors :
Maria Noemia Martins de Lima، نويسنده , , Caroline Piet? Dias، نويسنده , , Juliana Presti-Torres، نويسنده , , Arethuza Dornelles، نويسنده , , Vanessa Atha?de Garcia، نويسنده , , Felipe Siciliani Scalco، نويسنده , , Marcelo Rewsaat Guimar?es، نويسنده , , Roberta Cristina Petry، نويسنده , , Elke Bromberg، نويسنده , , Larissa Constantino، نويسنده , , Patricia Budni، نويسنده , , Felipe Dal-Pizzol، نويسنده , , Nadja Schr?der، نويسنده ,
Abstract :
It is now generally accepted that iron accumulates in the brain during the ageing process. Increasing evidence demonstrate that iron accumulation in selective regions of the brain may generate free radicals, thereby possessing implications for the etiology of neurodegenerative disorders. In a previous study we have reported that aged rats present recognition memory deficits. The aim of the present study was to evaluate the effect of desferoxamine (DFO), an iron chelator agent, on age-induced memory impairment. Aged Wistar rats received intraperitoneal injections of saline or DFO (300 mg/kg) for 2 weeks. The animals were submitted to a novel object recognition task 24 h after the last injection. DFO-treated rats showed normal recognition memory while the saline group showed long-term recognition memory deficits. The results show that DFO is able to reverse age-induced recognition memory deficits. We also demonstrated that DFO reduced the oxidative damage to proteins in cortex and hippocampus. Thus, the present findings provide the first evidence that iron chelators might prevent age-related memory dysfunction.
Keywords :
aging , desferoxamine , Recognition memory , neuroprotection , Iron , oxidative stress , Protein carbonyl , rat